#United States #Denver #Chronic Pain #Lin Health #Virtual Recovery

Lin Health Secures $11 Million Series A Financing to Advance Virtual Chronic Pain Recovery

Lin Health, a pioneering company in the field of behavioral care for chronic pain, has successfully closed an oversubscribed Series A funding round, raising $11 million. This significant investment highlights not only strong investor confidence but also the urgent need for effective solutions to the chronic pain crisis in healthcare. Chronic pain is a widespread issue that, in terms of costs, surpasses even diabetes and cancer combined, costing approximately $635 billion annually in the U.S.

The funding round was led by Proofpoint Capital, a venture firm known for its focus on healthcare innovation, alongside new investments from firms like Osage Venture Partners and NewHealth Ventures. Existing investors, including the prestigious Mayo Clinic and Saban Ventures, also contributed, demonstrating a robust commitment to Lin Health’s mission.

Addressing the Chronic Pain Crisis

CEO and co-founder Yehuda Kogan stated, "This milestone reflects the confidence of our investors and the urgency of addressing our growing chronic pain crisis, as at least one in five doctor visits are tied to pain." This statistic underscores the importance of Lin Health's work as it focuses on delivering compassionate, evidence-based treatments through a virtual platform.

Lin Health partners with a range of healthcare providers, including major health systems and clinics, to offer virtual chronic pain treatment that is both effective and non-opioid. The platform is designed to provide care for conditions ranging from migraines and irritable bowel syndrome (IBS) to back pain and joint issues. The service is currently available to over 60 million Americans, aiming to engage patients with multiple high-touch interactions each week.

Innovative Approach to Pain Treatment

The platform employs a physician-led and coach-supported model, fully supported by rigorous clinical research and tailored to align with national pain management guidelines. Lin Health's approach includes using advanced technology to enhance patient engagement and streamline care processes, ultimately improving outcomes while managing costs effectively. According to Dan Goldsmith of Proofpoint Capital, "Lin Health's model doesn't just deliver meaningful outcomes for patients; it also addresses systemic inefficiencies and financial realities for payers and care teams."

The funding will not only enhance product innovation but also expand the company's market presence and strengthen clinically integrated partnerships. As stated in a quote from Kogan, "We've proven our mission-driven model delivers results for patients and payers alike, and we are prepared to accelerate our growth and further our efforts to bring relief to the millions suffering from chronic pain in America."

The Path Forward for Lin Health

Lin Health’s strategy capitalizes on leveraging technology and artificial intelligence to scale operations and enhance the care experience for both patients and clinicians. This funding marks a pivotal moment for Lin Health as it seeks to redefine how chronic pain is treated across the country.

By using innovative techniques like Pain Reprocessing Therapy, Cognitive Behavioral Therapy, and Emotional Awareness and Expression Therapy, Lin aims to retrain maladaptive pain circuits and restore functionality. The focus on bridging medical and behavioral treatments positions Lin as a frontrunner in tackling a complex and often overlooked challenge in American healthcare.

As Lin Health moves forward, it remains committed to enhancing population health, reducing provider burnout, and ensuring sustainable outcomes in chronic pain management. With a clear vision and strong backing from investors, Lin Health is set to play a crucial role in transforming chronic pain treatment and fundamentally improving lives across the nation.

To learn more about Lin Health and its mission, visit Lin Health.